Symbol="ANAB"
AssetType="Common Stock"
Name="AnaptysBio Inc"
Description="AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company is headquartered in San Diego, California."
CIK="1370053"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10421 PACIFIC CENTER COURT, SUITE 200, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="489219000"
EBITDA="-130327000"
PERatio="None"
PEGRatio="0"
BookValue="7.07"
DividendPerShare="0"
DividendYield="0"
EPS="-4.97"
RevenuePerShareTTM="0.379"
ProfitMargin="0"
OperatingMarginTTM="-12.25"
ReturnOnAssetsTTM="-0.139"
ReturnOnEquityTTM="-0.524"
RevenueTTM="10691000"
GrossProfitTTM="-78511000"
DilutedEPSTTM="-4.97"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.416"
AnalystTargetPrice="32.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="178.16"
PriceToBookRatio="3.005"
EVToRevenue="91.55"
EVToEBITDA="-3.592"
Beta="-0.135"
num_52WeekHigh="32.44"
num_52WeekLow="18"
num_50DayMovingAverage="19.61"
num_200DayMovingAverage="24.12"
SharesOutstanding="26487200"
DividendDate="None"
ExDividendDate="None"
symbol="ANAB"
open="18.52"
high="18.69"
low="18.00"
price="18.47"
volume="395612.00"
latest_trading_day="2023-07-14"
previous_close="18.60"
change="-0.13"
change_percent="-0.6989%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="211203"
Change_recent_avg="-0.08"
Delta_recent_avg="0.96"
Variance_recent_avg="0.48"
Change_ratio_recent_avg="-0.39"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="93"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0083.jpeg"
image_negative_thumbnail_id_2="514"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="663"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_positive_thumbnail_id_2="963"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
